CN1449766A - Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof - Google Patents
Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof Download PDFInfo
- Publication number
- CN1449766A CN1449766A CN 03116421 CN03116421A CN1449766A CN 1449766 A CN1449766 A CN 1449766A CN 03116421 CN03116421 CN 03116421 CN 03116421 A CN03116421 A CN 03116421A CN 1449766 A CN1449766 A CN 1449766A
- Authority
- CN
- China
- Prior art keywords
- flos lonicerae
- volatile oil
- extract
- coptis
- capsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 241000205585 Aquilegia canadensis Species 0.000 title claims description 11
- 239000007901 soft capsule Substances 0.000 title abstract description 4
- 239000009916 yin-huang Substances 0.000 title abstract description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000000341 volatile oil Substances 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 20
- 239000002775 capsule Substances 0.000 claims abstract description 17
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims abstract description 15
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims abstract description 15
- 229960003321 baicalin Drugs 0.000 claims abstract description 15
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000011187 glycerol Nutrition 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000003381 stabilizer Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 40
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 238000010009 beating Methods 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000013557 residual solvent Substances 0.000 claims description 3
- 238000001256 steam distillation Methods 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 claims description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 2
- 229960002216 methylparaben Drugs 0.000 claims description 2
- GJLNWLVPAHNBQN-UHFFFAOYSA-N phenyl 4-hydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OC1=CC=CC=C1 GJLNWLVPAHNBQN-UHFFFAOYSA-N 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 241000218202 Coptis Species 0.000 claims 6
- 241000215452 Lotus corniculatus Species 0.000 claims 1
- 239000002552 dosage form Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 241000245240 Lonicera Species 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 244000247747 Coptis groenlandica Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 206010001093 acute tonsillitis Diseases 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000007766 cera flava Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- -1 filters Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a yinhuang soft capsule oral medicine preparation and its preparation method. The liquid medicine contains extract of lonicera flower, baicalin, flonicera flower volatile oil, solvent and stabilizing agent. The mixing ratio of gelating and glycerine is 10:3.15-3.35 (weight ratio) in the capsule shell, and the preservative also is contained. When it is prepared, firstly, the lonicera flower volatile oil is extracted, then the press process if adopted so as to obtain the invented soft capsule. As compared with existent dosage form of yinhuang said invention has the advantages of stable quality, convenient for carryover and administration and quick dissolution of effective component.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of Silver yellow capsule preparation and its preparation method that is used for the treatment of diseases such as upper respiratory tract infection, acute tonsillitis, pharyngitis.
Background technology
Silver yellow has the effect of heat clearing away, detoxifcation, sore-throat relieving, is used for acute tonsillitis, upper respiratory tract infection and wind-heat invading the lung and causes diseases such as heating, cough, pharyngalgia.Silver yellow pin, sheet, granule and the oral liquid etc. made with Flos Lonicerae and Radix Scutellariae extract all come out.YINHUANG ZHUSHEYE patient's administration inconvenience, simultaneously in the preparation main component chlorogenic acid and baicalin put for a long time under solution condition can oxidative degradation, quality is unstable and affect the treatment, safety also can not get assurance.Though the simple cost of tablet technology is low, disintegrate absorbs slow curative effect and is affected; Oral liquid carries transportation inconvenience, the granule inconvenience of taking medicine.In addition, the volatile oil component of Flos Lonicerae also has the effect of heat-clearing and toxic substances removing, and all silver yellow oral formulations all do not keep the volatile oil component of Flos Lonicerae in preparation process.
Summary of the invention
The object of the present invention is to provide a kind of capsules of honeysuckle flower and coptis and preparation method thereof, product is an oral administered dosage form, and its steady quality is easy to use effective.
Capsules of honeysuckle flower and coptis proposed by the invention is made up of medicinal liquid and softgel shell two parts.Its herb liquid contains active ingredient Flos Lonicerae extract, baicalin, Flos Lonicerae volatile oil, also contains stabilizing agent, and active ingredient is dissolved in the solvent; Softgel shell mainly is made up of gelatin and glycerol, and the weight proportion of gelatin and glycerol is 10: 3.15～10: 3.35, is added with an amount of antiseptic in addition.
Solvent of the present invention can be one or more in liquid polyethylene glycol, isopropyl alcohol, tween 80, glycerol, propylene glycol, water and the vegetable oil (as Oleum Glycines, Oleum Arachidis hypogaeae semen, Oleum Camelliae etc.).
Antiseptic can be one or more in glycerol, propylene glycol, methyl parahydroxybenzoate, ethylparaben, propyl p-hydroxybenzoate, butyl p-hydroxybenzoate, benzyl p-hydroxybenzoate, the P-hydroxybenzoic acid phenyl ester.
Stabilizing agent can be one or more in water, glycerol, tween 80, ethyoxyl castor oil hydrogenated, soybean lecithin, Cera Flava, aluminum monostearate, ethyl cellulose, the solid polyethylene glycol.
Among the present invention, the reasonable weight proportion of medicinal liquid is as follows:
Flos Lonicerae extract 1
Baicalin 1～4
The Flos Lonicerae volatile oil corresponding amount extracted amount of volatile oil in the Flos Lonicerae of said extracted thing amount (promptly corresponding to)
Solvent 3.5～15
Stabilizing agent 0.4～2
Effective component content in every silver yellow capsule is fixed, and usually, content is that Flos Lonicerae extract is 0.04～0.08g, and baicalin is 0.08～0.16g, and Flos Lonicerae volatile oil is a corresponding amount.Wherein, the best proportioning of Flos Lonicerae extract and baicalin is 1: 2.
Gelatin, glycerol proportioning are difficult to grasp in the prescription of softgel shell.The amount of glycerol is too many, and softgel shell is softer, than being easier to extrusion; The amount of glycerol very little, softgel shell is harder, crisp, influences the quality stability and the disintegration time of soft capsule.Gelatin, glycerol proportioning to softgel shell have been carried out detailed experimental study, have obtained a proportioning preferably at last.
An amount of gelatin is added in the rustless steel glue pot, add suitable quantity of water again, airtight, 70 degree insulation 3hr, add glycerol, the antiseptic of test consumption more respectively, stir vacuumize degassing 2hr, put into gelatin heat-preserving container 70 degree insulation standing over night, second day moulding ball, drying at room temperature keeps sample and investigates 3 months, examination softgel shell outward appearance and physical property, found that gelatin and glycerol proportioning be 10: 3.15～3.35 o'clock the most suitable.The softgel shell prescription that is filtered out is applicable to the environment of warm moist.
The preparation technology of capsules of honeysuckle flower and coptis may further comprise the steps:
Flos Lonicerae is collected volatile oil and Flos Lonicerae medicinal residues with steam distillation or carbon dioxide supercritical extraction method extraction volatile oil wherein.The reuse conventional method is extracted Flos Lonicerae extract from medicinal residues.Detailed process is as follows: medicinal residues decoct with water secondary, and 1 hour for the first time, gradation in 45 minutes was for the second time filtered, and filtrate merging is evaporated to every ml and is equivalent to Flos Lonicerae 2g, add 20% lime cream, regulate pH to 12～13 and stir evenly, leave standstill, filter, discard filtrate, precipitation adds 2 times of amount ethanol and stirs evenly, cross sieve No. 4, regulate pH to 3～4, stir evenly with 50% sulfuric acid solution, filter, filtrate is neutralized to pH6.5～7.0 with 40%NaOH, filters, filtrate decompression is condensed into the thick paste shape, drying, promptly.
Flos Lonicerae extract and baicalin are pressed prescription proportioning mixing, after beating powder and crossing the 80-120 mesh sieve, feed intake by the prescription proportioning, elder generation in partial solvent, joins the stabilizing agent thermosol with the thermosol thing in the residual solvents that are preheated to 35～45 degree more lentamente, the limit edged stirs, add solid and Flos Lonicerae volatile oil then, it is moistening fully fully to mix assurance, crosses colloid mill and pulverizes the back pelleting, drying, promptly.
Good effect of the present invention has provided a kind of capsules of honeysuckle flower and coptis preparation and preparation technology thereof, product is an oral administered dosage form, can overcome the shortcoming of existing dosage form, the bioavailability height satisfies the standard of such dosage form aspect outward appearance, hardness, disintegration etc. and physical and chemical stability.
The specific embodiment
Further specifically describe the present invention below by embodiment.
Embodiment 1:
Component amount (gram/grain)
Flos Lonicerae extract 0.06
Baicalin 0.12
The Flos Lonicerae volatile oil corresponding amount
Polyethylene Glycol 0.41
Glycerol 0.035
Water is an amount of
Capsule shells 0.20
Embodiment 2:
Component amount (gram/grain)
Flos Lonicerae extract 0.04
Baicalin 0.08
The Flos Lonicerae volatile oil corresponding amount
Isopropyl alcohol 0.25
Ethyoxyl castor oil hydrogenated 0.03
Glycerol 0.02
Water is an amount of
Capsule shells 0.17
Embodiment 3:
Component weight (gram/grain)
Flos Lonicerae extract 0.08
Baicalin 0.16
The Flos Lonicerae volatile oil corresponding amount
Semen Maydis oil 0.60
Soybean lecithin 0.02
Cera Flava 0.04
Water is an amount of
Capsule shells 0.19
The preparation technology of embodiment is as follows:
Flos Lonicerae is collected volatile oil and Flos Lonicerae medicinal residues with steam distillation or carbon dioxide supercritical extraction method extraction volatile oil wherein, and medicinal residues extract to handle in accordance with the law and obtain Flos Lonicerae extract.Medicinal residues decoct with water secondary, and 1 hour for the first time, gradation in 45 minutes was for the second time filtered, and filtrate merging is evaporated to every ml and is equivalent to Flos Lonicerae 2g, add 20% lime cream, regulate pH to 12～13 and stir evenly, leave standstill, filter, discard filtrate, precipitation adds 2 times of amount ethanol and stirs evenly, cross sieve No. 4, regulate pH to 3～4, stir evenly with 50% sulfuric acid solution, filter, filtrate is neutralized to pH6.5～7.0 with 40%NaOH, filters, filtrate decompression is condensed into the thick paste shape, and drying obtains Flos Lonicerae extract.
Flos Lonicerae extract and baicalin are pressed prescription proportioning mixing, after beating powder and crossing 100 mesh sieves, feed intake by the prescription proportioning, elder generation in partial solvent, joins the stabilizing agent thermosol with the thermosol thing in the residual solvents that are preheated to 40 degree more lentamente, the limit edged stirs, add solid and Flos Lonicerae volatile oil then, it is moistening fully fully to mix assurance, crosses colloid mill and pulverizes the back pelleting, drying, promptly.
Claims (6)
1, a kind of capsules of honeysuckle flower and coptis, form by medicinal liquid and softgel shell two parts, it is characterized in that herb liquid contains active ingredient Flos Lonicerae extract, baicalin, Flos Lonicerae volatile oil, and contain stabilizing agent, active ingredient is dissolved in the solvent, softgel shell mainly contains gelatin and glycerol is formed, and is added with an amount of antiseptic, and the weight proportion of gelatin and glycerol is 10: 3.15～10: 3.35.
2, capsules of honeysuckle flower and coptis according to claim 1 is characterized in that solvent is one or more in liquid polyethylene glycol, isopropyl alcohol, tween 80, glycerol, propylene glycol, water and the vegetable oil.
3, capsules of honeysuckle flower and coptis according to claim 1 is characterized in that antiseptic is one or more in glycerol, propylene glycol, methyl parahydroxybenzoate, ethylparaben, propyl p-hydroxybenzoate, butyl p-hydroxybenzoate, benzyl p-hydroxybenzoate, the P-hydroxybenzoic acid phenyl ester.
4,, it is characterized in that the weight proportion of medicinal liquid is as follows according to the described capsules of honeysuckle flower and coptis of claim 1-3:
Flos Lonicerae extract 1
Baicalin 1～4
The Flos Lonicerae volatile oil corresponding amount
Solvent 3.5～15
Stabilizing agent 0.4～2
5, a kind of preparation method as the described capsules of honeysuckle flower and coptis of claim 1-4 is characterized in that may further comprise the steps:
Flos Lonicerae extract and baicalin by prescription proportioning mixing, after beating powder and crossing the 80-120 mesh sieve, are fed intake by the prescription proportioning, earlier with the stabilizing agent thermosol in partial solvent, again the thermosol thing is joined lentamente in the residual solvents that are preheated to 35～45 degree the stirring of limit edged; Add ground honeysuckle extract, baicalin and Flos Lonicerae volatile oil then, it is moistening fully fully to mix assurance; Cross colloid mill and pulverize the back pelleting, drying, promptly.
6, the preparation method of capsules of honeysuckle flower and coptis according to claim 5 is characterized in that adopting steam distillation or carbon dioxide supercritical extraction method to extract Flos Lonicerae volatile oil from Flos Lonicerae; The reuse conventional method is extracted Flos Lonicerae extract from the Flos Lonicerae medicinal residues.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031164218A CN100367968C (en) | 2003-04-16 | 2003-04-16 | Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031164218A CN100367968C (en) | 2003-04-16 | 2003-04-16 | Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1449766A true CN1449766A (en) | 2003-10-22 |
| CN100367968C CN100367968C (en) | 2008-02-13 |
Family
ID=28684172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031164218A Expired - Fee Related CN100367968C (en) | 2003-04-16 | 2003-04-16 | Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100367968C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330312C (en) * | 2005-06-27 | 2007-08-08 | 宛六一 | Baicalin soft capsule and preparation method thereof |
| CN1939409B (en) * | 2006-10-23 | 2010-12-15 | 石药集团欧意药业有限公司 | Capsules of honeysuckle flower and coptis and preparation thereof |
| CN104000874A (en) * | 2014-06-06 | 2014-08-27 | 余中华 | Honeysuckle flower-baikal skullcap root granules and preparation method thereof |
| CN104922208A (en) * | 2015-06-28 | 2015-09-23 | 赵明亮 | Preparation method and application of Yinhuang granules |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12168018B1 (en) | 2023-09-14 | 2024-12-17 | Consortium “Ukrindustry” | Pharmacologically active liposomal composition comprising quercetin and zinc |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1398626A (en) * | 2002-08-23 | 2003-02-26 | 李大鹏 | Yinhuang powder injection for intravenous injection and its prepn process |
-
2003
- 2003-04-16 CN CNB031164218A patent/CN100367968C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330312C (en) * | 2005-06-27 | 2007-08-08 | 宛六一 | Baicalin soft capsule and preparation method thereof |
| CN1939409B (en) * | 2006-10-23 | 2010-12-15 | 石药集团欧意药业有限公司 | Capsules of honeysuckle flower and coptis and preparation thereof |
| CN104000874A (en) * | 2014-06-06 | 2014-08-27 | 余中华 | Honeysuckle flower-baikal skullcap root granules and preparation method thereof |
| CN104922208A (en) * | 2015-06-28 | 2015-09-23 | 赵明亮 | Preparation method and application of Yinhuang granules |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100367968C (en) | 2008-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11957659B2 (en) | Transmucosal dephosphorylated psychoactive alkaloid composition and preparation thereof | |
| CN101062289A (en) | External application medicine combination for treating gout | |
| CN1215861C (en) | Xiasangju effervescent tablet and its preparation process | |
| CN1449766A (en) | Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof | |
| CN101856489B (en) | Swine health granules and preparation process thereof | |
| CN114712475B (en) | Dai medicine composition for preventing and/or treating reperfusion injury after myocardial ischemia and preparation method and application thereof | |
| CN1259038C (en) | Radix bupleuri soft capsule pharmaceutics and preparation process thereof | |
| CN1723945A (en) | Novel oral liquor for invigorating spleen, and prepn. method and quality control therefor | |
| CN115844920A (en) | Application of caulerpa lentillifera polysaccharide in preparation of medicine for treating osteoporosis | |
| CN100457151C (en) | Chinese goldthread soft capsule for clearing away adverse lung energy and its prepn process | |
| CN100363018C (en) | Honeysuckle soft capsule preparation and preparation method thereof | |
| CN1628754A (en) | Local externally applied itch stopping garlic paint | |
| CN101066355A (en) | Chinese medicine prepn for treating toothache and its prepn process | |
| US20150125555A1 (en) | Pharmacological use of cimicifuga extract | |
| RU2802434C1 (en) | Mixture of ziziphus jujube mill. fruit extracts with anti-ulcer and anti-inflammatory actions | |
| CN118649442B (en) | Traditional Chinese medicine composition for reducing uric acid obtained through liquid-liquid extraction | |
| CN1724061A (en) | Traditional Chinese medicine prepn. for warming middle-jiao to dispel-cold and recuperating depleted yang and rescuing the patient from collapse, and its prepn. method | |
| CN100358553C (en) | Chinese medicine composition for lowering blood fat and reducing weight and preparation thereof | |
| CN1730059A (en) | Yanning capsule and its preparation process | |
| CN1679649A (en) | Medicinal composition for cervical erosion and vaginitis and its preparation | |
| CN1899388A (en) | Shuangdan soft capsule and its preparing method | |
| CN1490025A (en) | Bear gall granular formulation and preparing method thereof | |
| CN1628799A (en) | Soft capsule containing clove leaf extract and preparation process thereof | |
| CN1589827A (en) | Medicine for treating common cold and cough | |
| CN1745837A (en) | Funing preparation and its making method theref |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Yanzhou Hill Kangtai Pharmaceutical Co., Ltd. Assignor: Botai Medicine Science and Technology Co., Ltd., Shanghai Contract fulfillment period: 2008.12.29 to 2023.4.15 contract change Contract record no.: 2009370000076 Denomination of invention: Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof Granted publication date: 20080213 License type: Exclusive license Record date: 2009.4.24 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.12.29 TO 2023.4.15; CHANGE OF CONTRACT Name of requester: YANZHOU HILL KANGTAI PHARMACEUTICAL CO., LTD. Effective date: 20090424 |
|
| ASS | Succession or assignment of patent right |
Owner name: YANZHOU HILL KANGTAI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI BOTAI PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20091023 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20091023 Address after: Xin Yan Zhen private industrial park in Shandong city of Yanzhou Province Patentee after: Yanzhou Hill Kangtai Pharmaceutical Co., Ltd. Address before: Room 335, No. 3021, National Road, Shanghai, China Patentee before: Botai Medicine Science and Technology Co., Ltd., Shanghai |
|
| C56 | Change in the name or address of the patentee |
Owner name: SHANDONG XI ER KANGTAI PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: YANZHOU XI ER KANGTAI PHARMACEUTICAL CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: Xin Yan Zhen Private Industrial Park Jining city Yanzhou City, Shandong province 272100 Patentee after: SHANDONG XIER KANGTAI PHARMACEUTICAL CO., LTD. Address before: Xin Yan Zhen Private Industrial Park 272100 Shandong city of Yanzhou Province Patentee before: Yanzhou Hill Kangtai Pharmaceutical Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080213 Termination date: 20150416 |
|
| EXPY | Termination of patent right or utility model |